Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Anderson GM 3d, Braun G, ... |
Absolute configuration and psychotomimetic activity |
NIDA Res Monogr |
1978 |
Beardsley PM, Balster RL,... |
Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... |
Drug Alcohol Depend |
1986 |
Beck J |
MDMA: The popularization and resultant implications of a recently cont... |
Contemporary Drug Pr... |
1986 |
Downing J |
The psychological and physiological effects of MDMA on normal voluntee... |
J Psychoactive Drugs |
1986 |
Hayner GN, McKinney H |
MDMA. The dark side of ecstasy |
J Psychoactive Drugs |
1986 |
Newmeyer JA |
Some considerations on the prevalence of MDMA use |
J Psychoactive Drugs |
1986 |
Schmidt CJ, Wu L, Lovenbe... |
Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... |
Eur J Pharmacol |
1986 |
Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
Mokler DJ, Robinson SE, R... |
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... |
Eur J Pharmacol |
1987 |
Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
Ruangyuttikarn W, Moody D... |
Comparison of three commercial amphetamine immunoassays for detection ... |
J Anal Toxicol |
1988 |
Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
Battaglia G, De Souza EB |
Pharmacologic profile of amphetamine derivatives at various brain reco... |
NIDA Res Monogr |
1989 |
Dimpfel W, Spuler M, Nich... |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... |
Psychopharmacology (... |
1989 |
Gold LH, Geyer MA, Koob G... |
Psychostimulant properties of MDMA |
NIDA Res Monogr |
1989 |
Gold LH, Geyer MA, Koob G... |
Neurochemical mechanisms involved in behavioral effects of amphetamine... |
NIDA Res Monogr |
1989 |
Gold LH, Koob GF |
MDMA produces stimulant-like conditioned locomotor activity |
Psychopharmacology (... |
1989 |
Li AA, Marek GJ, Vosmer G... |
Long-term central 5-HT depletions resulting from repeated administrati... |
Pharmacol Biochem Be... |
1989 |
Nader MA, Hoffmann SM, Ba... |
Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... |
Psychopharmacology (... |
1989 |
Slikker W Jr, Holson RR, ... |
Behavioral and neurochemical effects of orally administered MDMA in th... |
Neurotoxicology |
1989 |
Azmitia EC, Murphy RB, Wh... |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... |
Brain Res |
1990 |
Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
Cody JT |
Detection of D,L-amphetamine, D,L-methamphetamine, and illicit ampheta... |
J Anal Toxicol |
1990 |
Cody JT |
Cross-reactivity of amphetamine analogues with Roche Abuscreen radioim... |
J Anal Toxicol |
1990 |
Davies JB, Ditton J |
The 1990s: decade of the stimulants? |
Br J Addict |
1990 |
De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
Kunsman GW, Manno JE, Coc... |
Application of the Syva EMIT and Abbott TDx amphetamine immunoassays t... |
J Anal Toxicol |
1990 |
Nash JF |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in th... |
Life Sci |
1990 |
Nichols DE, Oberlender R |
Structure-activity relationships of MDMA and related compounds: a new ... |
Ann N Y Acad Sci |
1990 |
Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
Piercey MF, Lum JT, Palme... |
Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminer... |
Brain Res |
1990 |
Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
Schmidt CJ, Taylor VL |
Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by ... |
Eur J Pharmacol |
1990 |
Yousif MY, Fitzgerald RL,... |
Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... |
Drug Alcohol Depend |
1990 |
Greer GR,Tolbert R |
The Therapeutic Use of MDMA |
Ecstasy: The clinica... |
1990 |
McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
Paris JM, Cunningham KA |
Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... |
NIDA Res Monogr |
1991 |
Ali SF, Chang LW, Slikker... |
Biogenic amines as biomarkers for neurotoxicity |
Biomed Environ Sci |
1991 |
Battaglia G, Sharkey J, K... |
Neuroanatomic specificity and time course of alterations in rat brain ... |
Synapse |
1991 |
Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
Gan BK, Baugh D, Liu RH, ... |
Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methyl... |
J Forensic Sci |
1991 |
Glennon RA |
Phenylalkylamine stimulants, hallucinogens, and designer drugs |
NIDA Res Monogr |
1991 |
Hiramatsu M, DiStefano E,... |
A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effect... |
Eur J Pharmacol |
1991 |
Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
Johnson MP, Huang XM, Nic... |
Serotonin neurotoxicity in rats after combined treatment with a dopami... |
Pharmacol Biochem Be... |
1991 |
Kumagai Y, Lin LY, Schmit... |
Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl co... |
Chem Res Toxicol |
1991 |
Millan MJ, Colpaert FC |
Methylenedioxymethamphetamine induces spontaneous tail-flicks in the r... |
Eur J Pharmacol |
1991 |
Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
Henry JA, Jeffreys KJ, Da... |
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') |
Lancet |
1992 |
Gouzoulis E, Steiger A, E... |
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... |
Biol Psychiatry |
1992 |
Callaway CW, Rempel N, Pe... |
Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... |
Neuropsychopharmacol... |
1992 |
Elayan I, Gibb JW, Hanson... |
Long-term alteration in the central monoaminergic systems of the rat b... |
Eur J Pharmacol |
1992 |
Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
Helmlin HJ, Brenneisen R |
Determination of psychotropic phenylalkylamine derivatives in biologic... |
J Chromatogr |
1992 |
Henry JA |
Ecstasy and the dance of death |
BMJ |
1992 |
Herndon JL, Pierson ME, G... |
Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... |
Pharmacol Biochem Be... |
1992 |
Huang X, Marona-Lewicka D... |
p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... |
Eur J Pharmacol |
1992 |
Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
Liester MB, Grob CS, Brav... |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use |
J Nerv Ment Dis |
1992 |
Paris JM, Cunningham KA |
Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... |
Brain Res Bull |
1992 |
Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
Solowij N, Hall W, Lee N |
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and thei... |
Br J Addict |
1992 |
Thurman EM, Pedersen MJ, ... |
Distinguishing sympathomimetic amines from amphetamine and methampheta... |
J Anal Toxicol |
1992 |
Huang X, Marona-Lewicka D... |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... |
Eur J Pharmacol |
1992 |
Heilig, Steve |
MDMA Update: The Science and Politics of Ecstasy |
Newsletter of the Ca... |
1993 |
Stolaroff MJ, Wells CW |
Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 |
Yearbook for Ethnome... |
1993 |
Wodarz N |
'Ecstasy'-induced psychotic depersonalization syndrome |
Nervenarzt |
1993 |
Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
Cregg MT, Tracey JA |
Ecstasy abuse in Ireland |
Ir Med J |
1993 |
McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
Rudnick G, Wall SC |
Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... |
Mol Pharmacol |
1993 |
Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
Cassidy G, Ballard CG |
Psychiatric sequelae of MDMA (ecstasy) and related drugs |
Irish Journal of Psy... |
1994 |
Hooft PJ, van de Voorde H... |
Reckless behaviour related to the use of 3,4-methylenedioxymethampheta... |
Int J Legal Med |
1994 |
Kramer K, Azmitia EC, Whi... |
In vitro release of [3H]5-hydroxytryptamine from fetal and maternal br... |
Brain Res Dev Brain ... |
1994 |
McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
McGuire PK, Cope H, Fahy ... |
Diversity of psychopathology associated with use of 3,4-methylenedioxy... |
Br J Psychiatry |
1994 |
O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
Snape MF, Colado MI, et a... |
Chlormethiazole and dizocilpine block the behavioural, but not the neu... |
Pharmacol Toxicol |
1994 |
Ward C, McNally AJ, Rusyn... |
125I radioimmunoassay for the dual detection of amphetamine and metham... |
J Forensic Sci |
1994 |
Harlow D, Galloway G, Jes... |
Raves and Drug Use: An Exploratory Study |
Botec Analysis |
1994 |
McDermott P |
MDMA Use in the North West of England |
International Journa... |
1994 |
Heilig,S |
Book Review: Pursuit of Ecstasy: The MDMA Experience by Beck, J & Rose... |
Journal of Psychoact... |
1994 |
Cadet JL, Ladenheim B, Hi... |
Superoxide radicals mediate the biochemical effects of methylenedioxym... |
Synapse |
1995 |
Campbell DB |
The use of toxicokinetics for the safety assessment of drugs acting in... |
Mol Neurobiol |
1995 |
Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
Cirimele V, Kintz P, Mang... |
Detection of amphetamines in fingernails: an alternative to hair analy... |
Arch Toxicol |
1995 |
Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |